Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression

Clinical and Experimental Immunology

Volumn 162, Issue 2, 2010, Pages 372-378

  Fitch, P M ^a   Wheelhouse, N M ^b   Bowles, P ^a   Paterson, M ^a   Longbottom, D ^b   Entrican, G ^b   Howie, S E M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Chlamydia pneumoniae; CXCL2 MIP 2; Epithelium; Lung; Lymphocytes

Indexed keywords

BACTERIAL DNA; CXCL2 CHEMOKINE; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELLULAR DISTRIBUTION; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DNA EXTRACTION; ECTOPIC TISSUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; LYMPHOID TISSUE; MACROPHAGE; MOUSE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; UPREGULATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CHEMOKINE CXCL2; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHORISTOMA; DNA, BACTERIAL; EPITHELIAL CELLS; GENE EXPRESSION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; LYMPHOCYTES; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; NEUTROPHILS; RESPIRATORY MUCOSA; TIME FACTORS;

EID: 78649238760     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04231.x     Document Type: Article

References (30)

1. Blasi F, Tarsia P, Aliberti S. Chlamydophila pneumoniae. Clin Microbiol Infect 2009; 15:29-35.
2. Blasi F, Damato S, Cosentini R et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 2002; 57:672-6.
3. Papaetis GS, Anastasakou E, Orphanidou D. Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence? Eur J Intern Med 2009; 20:579-85.
4. Giovannoni G, Cutter GR, Lunemann J et al. Infectious causes of multiple sclerosis. Lancet Neurol 2006; 5:887-94.
5. Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000; 181 (Suppl. 3):S402-10.
6. Gerard HC, Dreses-Werringloer U, Wildt KS et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol 2006; 48:355-66.
7. Cannon CP, Braunwald E, McCabe CH et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 2005; 352:1646-54.
8. Woessner R, Grauer MT, Frese A et al. Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis. Infection 2006; 34:342-4.
9. Richeldi L, Ferrara G, Fabbri LM, Lasserson TJ, Gibson PG. Macrolides for chronic asthma. Cochrane Database Syst Rev 2005; 3:CD002997.
10. Black PN, Blasi F, Jenkins CR et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. AmJ Respir Crit CareMed 2001; 164:536-41.
11. Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006; 354:1589-600.
12. Black PN. Antibiotics for the treatment of asthma.Curr Opin Pharmacol 2007; 7:266-71.
13. Kaukoranta-Tolvanen SE, Laurila AL, Saikku P, Leinonen M, Laitinen K. Experimental Chlamydia pneumoniae infection inmice: effect of reinfection and passive immunization. Microb Pathog 1995; 18:279-88.
14. Penttila JM, Anttila M, Puolakkainen M et al. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun 1998; 66:5113-18.
15. Blasi F, Aliberti S, Allegra L et al. Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice. Respir Res 2007; 8:83.
16. Faunce DE, Sonoda KH, Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 2001; 166:313-21.
17. New JY, Li B, Koh WP et al. T cell infiltration and chemokine expression: relevance to the disease localization in murine graftversus-host disease. Bone Marrow Transplant 2002; 29:979-86.
18. Ohtsuka Y, Lee J, Stamm DS, Sanderson IR. MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut 2001; 49:526-33.
19. Turhan A, Lin M, Lee GS et al. Vascular microarchitecture of murine colitis-associated lymphoid angiogenesis. Anat Rec (Hoboken) 2009; 292:621-32.
20. Spencer WN, Johnson FW. Simple transport medium for the isolation of Chlamydia psittaci from clinical material. Vet Rec 1983; 113:535-6.
21. Wheelhouse N, Wattegedera S, Fleming D, Fitch P, Kelly R, Entrican G. Chlamydia trachomatis and Chlamydophila abortus induce the expression of secretory leukocyte protease inhibitor in cells of the human female reproductive tract. Microbiol Immunol 2008; 52:465-8.
22. Leech MD, Benson RA,DeVries A, Fitch PM,Howie SE. Resolution of Der p1-induced allergic airway inflammation is dependent on CD4+CD25+Foxp3+ regulatory cells. J Immunol 2007; 179:7050-8.
23. Ehricht R, Slickers P, Goellner S, Hotzel H, Sachse K. Optimized DNA microarray assay allows detection and genotyping of single PCR-amplifiable target copies. Mol Cell Probes 2006; 20:60-3.
24. Graham SP, Jones GE, MacLean M, Livingstone M, Entrican G. Recombinant ovine interferon gamma inhibits the multiplication of Chlamydia psittaci in ovine cells. J Comp Pathol 1995; 112:185-95.
25. Haralambieva IH, Iankov ID, Petrov DP, Mladenov IV, Mitov IG. Monoclonal antibody of IgG isotype against a cross-reactive lipopolysaccharide epitope of Chlamydia and Salmonella Re chemotype enhances infectivity in L-929 fibroblast cells. FEMS Immunol Med Microbiol 2002; 33:71-6.
26. Magdaleno SM,Wang G, Jackson KJ et al. Interferon-gamma regulation of Clara cell gene expression: in vivo and in vitro. Am J Physiol 1997; 272:L1142-L1151.
27. Sanderson RD, Lalor P, Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1989; 1:27-35.
28. Kim CW, Goldberger OA, Gallo RL, Bernfield M. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 1994; 5:797-805.
29. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006; 6:205-17.
30. Carragher DM, Rangel-Moreno J, Randall TD. Ectopic lymphoid tissues and local immunity. Semin Immunol 2008; 20:26-42.